Kinaxis (TSE:KXS – Get Free Report) had its price objective boosted by stock analysts at National Bank Financial from C$200.00 to C$210.00 in a note issued to investors on Friday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. National Bank Financial’s price objective would indicate a potential upside of 20.59% from the stock’s previous close.
Several other analysts have also issued reports on KXS. Stifel Nicolaus reduced their target price on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Canadian Imperial Bank of Commerce raised their price target on shares of Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. BMO Capital Markets boosted their price target on shares of Kinaxis from C$180.00 to C$185.00 in a report on Friday, May 8th. Finally, Royal Bank Of Canada increased their price objective on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Seven analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of C$203.12.
Read Our Latest Stock Analysis on Kinaxis
Kinaxis Stock Up 2.5%
Kinaxis (TSE:KXS – Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. The company had revenue of C$230.64 million for the quarter. Kinaxis had a return on equity of 19.72% and a net margin of 14.48%. On average, research analysts expect that Kinaxis will post 4.2526231 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, Director Robert G. Courteau sold 5,010 shares of the firm’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the completion of the sale, the director directly owned 32,945 shares of the company’s stock, valued at C$4,987,543.55. This trade represents a 13.20% decrease in their position. Also, insider Conrad John Mandala sold 30,000 shares of Kinaxis stock in a transaction on Monday, May 11th. The stock was sold at an average price of C$148.10, for a total value of C$4,443,000.00. Following the sale, the insider owned 820 shares in the company, valued at C$121,442. The trade was a 97.34% decrease in their ownership of the stock. Insiders sold a total of 35,934 shares of company stock valued at $5,328,181 in the last 90 days. Corporate insiders own 1.20% of the company’s stock.
About Kinaxis
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Featured Stories
- Five stocks we like better than Kinaxis
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
